These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18683023)

  • 1. A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates.
    Mouri Y; Yoshida M; Nakano S; Yorozuya K; Fujii K; Fukutomi T; Nakaoka T; Yamada S; Hara K
    Breast Cancer; 2009; 16(2):147-50. PubMed ID: 18683023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
    Guarneri V; Miles D; Robert N; Diéras V; Glaspy J; Smith I; Thomssen C; Biganzoli L; Taran T; Conte P
    Breast Cancer Res Treat; 2010 Jul; 122(1):181-8. PubMed ID: 20361252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab.
    Ngamphaiboon N; Frustino JL; Kossoff EB; Sullivan MA; O'Connor TL
    Clin Breast Cancer; 2011 Aug; 11(4):252-7. PubMed ID: 21729657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].
    Iimura Y; Kaneko H; Hasegawa N; Takahashi Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1791-3. PubMed ID: 20841949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
    Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
    Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].
    Tanaka Y; Koga M; Yokomizo Y; Inokuchi S; Koga C; Kusukawa J
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):681-5. PubMed ID: 20414026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
    Longo R; Castellana MA; Gasparini G
    J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
    Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
    Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma.
    Goranova-Marinova VS; Pechalova-Petrova PF; Goranov SG
    Folia Med (Plovdiv); 2009; 51(4):53-7. PubMed ID: 20232660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series.
    Kumar SK; Meru M; Sedghizadeh PP
    J Contemp Dent Pract; 2008 Jan; 9(1):63-9. PubMed ID: 18176650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
    Fehm T; Beck V; Banys M; Lipp HP; Hairass M; Reinert S; Solomayer EF; Wallwiener D; Krimmel M
    Gynecol Oncol; 2009 Mar; 112(3):605-9. PubMed ID: 19136147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone.
    Christodoulou C; Pervena A; Klouvas G; Galani E; Falagas ME; Tsakalos G; Visvikis A; Nikolakopoulou A; Acholos V; Karapanagiotidis G; Batziou E; Skarlos DV
    Oncology; 2009; 76(3):209-11. PubMed ID: 19212145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases].
    Tohnosu N; Kobayashi Y; Saito T; Shimizu T; Natsume T; Tanaka H; Maruyama T; Watanabe Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):989-92. PubMed ID: 12894716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.